C32.3 — Malignant neoplasm of laryngeal cartilage
C32.3 is a billable, specific ICD-10-CM code for malignant neoplasm of laryngeal cartilage. It is valid for submission on a claim.
Other codes that can never be billed with C32.3
These codes carry an Excludes1 note pointing at C32.3. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading C32.3 alone.
Risk adjustment
C32.3 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C32.3 is named in 58 Medicare coverage policies — 58 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
Related codes at this level
Codes that share C32. If C32.3 is not quite right, the correct code is usually one of these.
Questions about C32.3
- Is C32.3 a billable ICD-10-CM code?
- Yes. C32.3 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C32.3 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of respiratory and intrathoracic organs (C30-C39).